课题基金 / 基金详情

Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology

Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology
胃癌预防:评估美国危险因素趋势和新技术
批准号:
8706073
负责人:
Jennifer M. Yeh
金额:
$15.02万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2016-05-31
关键词:
AgeAmericanBenefits and RisksBiological MarkersCancer ControlCancer EtiologyCancerousCessation of lifeClinicalClinical ResearchCohort StudiesCosts and BenefitsCross-Sectional StudiesDataData AnalysesDatabasesDiagnosticDiseaseDisease ProgressionEarly DiagnosisEarly treatmentEconomicsEffectivenessEnvironmentEpidemiologic MethodsEpidemiologyEthicsEthnic OriginExerciseFutureGastric Intestinal Type AdenocarcinomaGoalsGuidelinesHelicobacter pyloriImmigrantIncidenceIndividualInterventionKnowledgeLesionLife ExpectancyMalignant NeoplasmsMeasuresMedical SurveillanceMentorsMethodologyMethodsModelingNational Health and Nutrition Examination SurveyNatural HistoryOutcomeOutputPatientsPatternPoliciesPopulationPremalignantPrevalencePreventionPrevention programPrevention strategyPublishingRaceRecommendationRelative (related person)ResearchResearch DesignResearch PersonnelRisk FactorsRoleSEER ProgramScienceSerologic testsSmokingSocietiesStomachSubgroupSurveysTechniquesTechnologyTherapeuticTimeTrainingValidationbasecancer health disparitycancer preventioncareercost effectivenessdisease natural historyeffective interventionepidemiologic dataexperiencefallsflexibilitygastric cancer preventionhigh riskimprovedinsightmalignant stomach neoplasmmathematical modelmodels and simulationmodifiable riskmortalitymultidisciplinarynew technologynovel diagnosticsnovel therapeuticspopulation basedpreventscreeningskillssmoking cessationsmoking prevalencesurveillance datasurveillance strategytooltreatment strategytrend

项目摘要

项目成果

Jennifer M. Yeh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of the proposed research is to identify effective gastric cancer prevention programs that improve cancer outcomes, reduce disparities, and enhance the cost-effectiveness of gastric cancer prevention in the U.S. This will be accomplished by constructing a flexible decision-analytic simulation model of gastric cancer capable of estimating the contribution of risk factor patterns on gastric cancer trends and assessing the costs, benefits, and cost-effectiveness of primary (smoking cessation) and secondary (surveillance) prevention strategies. As several factors are changing the landscape of gastric cancer control, including a better understanding of the disease natural history, role of risk factors on disease progression, and new noninvasive endoscopic technology to detect and treat precancerous and cancerous lesions, this model will synthesize available clinical, epidemiologic, and economic data to project long-term outcomes and guide clinical study design. Our specific aims are: (1) to develop a natural history model of gastric cancer, including the role of risk factors on disease progression. This model will be empirically calibrated using U.S. epidemiologic data on age-specific prevalence and incidence of precancerous lesions and cancer; (2) to estimate the decline in gastric cancer incidence attributable to declining prevalence of H. pylori, smoking, and other risk factors. Using a population-based model of gastric cancer we will incorporate data on risk factor trends to forecast gastric cancer incidence and mortality; (3) to assess the cost-effectiveness of technology-based surveillance and treatment strategies for patients with precancerous lesions. We will evaluate the effectiveness of endoscopic and serology-based diagnostic and therapeutic technologies for dysplastic and asymptomatic cancerous lesions; (4) to compare the relative effectiveness of alternative gastric cancer control strategies on disparities. We will develop natural history models for specific race/ethnicity, immigrant, and other select subgroups, incorporate demographic trends, and assess the impact of prevention and treatment strategies to improve cancer outcomes and reduce disparities. In summary, this research will synthesize the best available data, improve upon an existing modeling framework, and develop a new set of analytic tools to estimate and project gastric cancer trends; establish management guidelines for patients with gastric precancerous lesions; and provide insight on the relative costs, benefits, and risks associated with different gastric cancer prevention and control strategies. My career goal is to become an independent investigator dedicated to the application of multidisciplinary, decision- analytic methods to improve cancer prevention and control policies. In conjunction with additional training in secondary data analysis, advanced decision-analytic methods, and epidemiology, the execution of this proposed mentored research in a multidisciplinary and highly-collaborative environment will provide the additional experience, knowledge, and skills needed to successfully transition to research independence.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10120-017-0693-x
发表时间: 2017-09
期刊: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
影响因子: --
作者: [Yeh JM, Tramontano AC, Hur C, Schrag D]
通讯作者: Schrag D
DOI: 10.1371/journal.pmed.1001451
发表时间: 2013
期刊: PLoS medicine
影响因子: 15.8
作者: [Yeh JM, Hur C, Schrag D, Kuntz KM, Ezzati M, Stout N, Ward Z, Goldie SJ]
通讯作者: Goldie SJ
DOI: 10.1136/gutjnl-2014-308588
发表时间: 2016-04
期刊: Gut
影响因子: 24.5
作者: [Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ]
通讯作者: Goldie SJ
DOI: 10.7326/m13-2266
发表时间: 2014-05-20
期刊: Annals of internal medicine
影响因子: 39.2
作者: [Yeh JM, Nohria A, Diller L]
通讯作者: Diller L
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
  • 批准号:
    10459788
  • 项目类别:
  • 资助金额:
    $75.55万
  • 财政年份:
    2022
  • 负责人:
    Jennifer M. Yeh
  • 依托单位:
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care
  • 批准号:
    10675772
  • 项目类别:
  • 资助金额:
    $64.4万
  • 财政年份:
    2022
  • 负责人:
    Jennifer M. Yeh
  • 依托单位:
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
  • 批准号:
    10231094
  • 项目类别:
  • 资助金额:
    $40.01万
  • 财政年份:
    2018
  • 负责人:
    Jennifer M. Yeh
  • 依托单位:
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
  • 批准号:
    9789024
  • 项目类别:
  • 资助金额:
    $40.34万
  • 财政年份:
    2018
  • 负责人:
    Jennifer M. Yeh
  • 依托单位:
海外基金